An Integrated, Stage-Gated R&D Process

Vaccelix Biopharma applies an integrated, stage-gated R&D framework that couples scientific rigor with operational discipline. Our approach reduces technical risk, accelerates decision-making, and aligns commercial, regulatory, and clinical objectives from day one.

Key Phases

• Discovery & Early Research: target identification, compound screening, and initial lead optimization using computational and experimental tools.
• Preclinical Development: in vitro and in vivo studies, ADME/Tox profiling, formulation feasibility and stability testing.
• Clinical Development: clinical trial design, GMP clinical supply, PK/PD studies, and regulatory interactions.
• Scale-up & Commercialization: process optimization, tech transfer, commercial manufacturing, and market release planning.

Cross-functional Capabilities

Our R&D teams integrate medicinal chemistry, formulation science, bioanalytical testing, process development, and regulatory affairs to create robust development pathways. We use data-driven decision making, quality-by-design principles, and predictive analytics to minimize surprises during scale-up and regulatory review.

Collaboration & Partnerships

Collaboration is central to our model. We partner with biotech innovators, academic institutions, and contract research organizations to access specialized expertise, accelerate timelines, and expand development capacity. Vaccelix acts as an extension of your team — sharing knowledge, resources, and accountability.

Discuss Your Project